---
accession : E-GEOD-53181
platform  : A-AGIL-28
pathway   : EGFR
cells     : PC-3 prostate cancer cell line
treatment : Gefitinib
effect    : inhibiting
hours     : 24

control   :
    - GSM1286085 1
    - GSM1286090 1
treatment :
    - GSM1286087 1
    - GSM1286092 1
...
